National Healthcare NHC Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Net margin | 8.1%+0.3pp | 7.8%+2.1pp | 5.7%+3.9pp | 1.8%-11.1pp | |
| Free cash flow margin | 9.8%+3.7pp | 6.1%-1.2pp | 7.3%— | —— | |
| Returns | |||||
| Return on equity | 12%+1.2pp | 10.8%+3.5pp | 7.3%+5.1pp | 2.2%-14.1pp | |
| Return on assets | 8%+0.8pp | 7.2%+2.2pp | 5%+3.6pp | 1.5%-8.6pp | |
| Efficiency | |||||
| Asset turnover | 1×+0.1× | 0.9×0.0× | 0.9×+0.1× | 0.8×0.0× | |
| Liquidity | |||||
| Current ratio | 1.8×0.0× | 1.8×-0.1× | 1.9×+0.1× | 1.8×+0.2× | |
| Quick ratio | 1.8×0.0× | 1.8×-0.1× | 1.9×+0.1× | 1.8×+0.2× | |
| Cash ratio | 0.4×0.0× | 0.3×-0.2× | 0.5×+0.2× | 0.3×-0.1× | |
| Leverage | |||||
| Debt-to-equity | 0.1×-0.1× | 0.2×+0.1× | 0.1×0.0× | 0.1×0.0× | |
| Debt-to-assets | 0.1×-0.1× | 0.1×+0.1× | 0.1×0.0× | 0.1×0.0× | |
| Valuation | |||||
| Market capitalization | $2.13B+28.1% | $1.66B+17.4% | $1.41B+54.9% | $912.97M-12.9% | |
| Enterprise value | $2.12B+17.9% | $1.8B+28.5% | $1.4B+42.2% | $985.23M-11.4% | |
| Price / earnings | 17.3×+1.1× | 16.3×-5.4× | 21.7×-24.0× | 45.7×+38.2× | |
| Price / sales | 1.4×+0.1× | 1.3×0.0× | 1.2×+0.4× | 0.8×-0.1× | |
| Price / book | 2×+0.3× | 1.7×+0.1× | 1.6×+0.5× | 1×-0.1× | |
| EV / sales | 1.4×0.0× | 1.4×+0.1× | 1.2×+0.3× | 0.9×-0.1× | |
| Free cash flow yield | 7%+2.2pp | 4.8%-1.1pp | 5.9%— | —— | |
| Earnings yield | 5.8%-0.4pp | 6.1%+1.5pp | 4.6%+2.4pp | 2.2%-11.1pp | |
| Dividend yield | 1.8%-0.4pp | 2.2%-0.3pp | 2.5%-1.3pp | 3.8%+0.7pp | |
| PEG ratio | 0.9×+0.6× | 0.3×+0.2× | 0.1×— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do National Healthcare's ratios come from?
- Every ratio is computed from National Healthcare's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
